This document discusses the issue of lung cancer in Asia. It notes that lung cancer is primarily caused by smoking, and Asia accounts for over 60% of global lung cancer cases due to its high smoking rates, particularly in China, India, Indonesia, and South Korea. However, the document also discusses the rise of non-smoking related lung cancer in Asia due to factors like air pollution, second-hand smoke, and exposure to asbestos, industrial pollution, and cooking oil particles. Countries like China and Taiwan are seeing increasing rates of adenocarcinoma lung cancer in non-smokers due to air quality issues.
Call Girls Secunderabad 7001305949 all area service COD available Any Time
Asia's Quiet War on Lung Cancer
1. eden strategy institute
H E A L T H C A R E
Asia’s
Quiet
War
on
Lung
Cancer
S O C I A L
I N N O V A T I O N
P L A Y B O O K
S E R I E S
2. 14
million
people
around
the
world
are
diagnosed
with
cancer
each
year
Source: Cancer Research UK 2014 eden strategy institute | 2
3. BACKGROUND
Source: Cancer Research UK 2014 eden strategy institute | 3
Lung
13%
Breast
12%
Bowel
10%
Prostate
8%
Others
57%
Most
Common
Cancers
Worldwide
Lung
cancer,
the
most
common
form
of
cancer,
accounted
for
1.8
million
cases
in
2012
1.8
m
New
Lung
Cancer
Cases
Worldwide
(2012)
4. BACKGROUND
This
is
a
serious
issue
in
Asia,
with
the
region
taking
up
more
than
60
percent
of
all
lung
cancer
cases
Source: Globocan 2012, Eden hospital interviews & analysis eden strategy institute | 4
India
Singapore
China
S.Korea
Japan
Taiwan
Hong
Kong
Philippines
Laos
Vietnam
Cambodia
Thailand
Pakistan
Afghanistan
Nepal
Mongolia
N.Korea
Malaysia
Sri
Lanka
<499
500-‐999
1,000-‐1,999
2,000-‐5,999
6,000-‐9,999
10,000-‐19,999
20,000-‐39,999
40,000
-‐100,000
>100,000
Butan
Blangladesh
Indonesia
Myanmar
Lung
Cancer
Incidence
within
Asia
(2012)
Countries
with
High
Lung
Cancer
Incidence
in
Asia
Country
Lung
Cancer
Incidence
China
725,359
India
145,000
Japan
94,855
Indonesia
34,695
Turkey
24,479
South
Korea
22,869
Vietnam
21,844
Thailand
19,501
North
Korea
13,851
Philippines
12,061
Taiwan
9,783
Others
66,418
5. OUR
STUDY
eden strategy institute | 5
This
paper
draws
insights
from
the
latest
developments
on
the
ongoing
baVle
against
lung
cancer
in
China,
Taiwan,
India,
and
South
Korea
6. CAUSES
OF
LUNG
CANCER:
SMOKING
Lung
cancer
is
primarily
driven
by
smoking,
and
is
highly
prevalent
in
countries
such
as
China,
India,
Indonesia,
and
South
Korea
There
are
one
billion
smokers
in
the
world,
with
more
than
70
percent
in
Asia
Source: WHO, Eden hospital interviews & analysis eden strategy institute | 6
7. CAUSES
OF
LUNG
CANCER:
SMOKING
China,
for
instance,
consists
of
more
than
300
million
smokers,
with
smokers
as
young
as
two
years
old
Source: WSJ (2013), Photo Credit: Reuters eden strategy institute | 7
“The
average
age
at
which
Chinese
people
start
smoking
is
four
to
five
years
younger
in
2002
compared
to
1984”
Ministry
of
Health
China
8. CAUSES
OF
LUNG
CANCER:
SMOKING
India
produces
700
billion
bidis
annually,
and
consumes
almost
all
of
them
locally
Source: The Times of India (2008), Photo Credit Paul Hamilton – Bidi Maker eden strategy institute | 8
“Bidi
may
contain
lesser
tobacco
than
cigareAes
–
0.2
grams,
but
delivers
as
much
or
more
tar
and
nico4ne”
Dr
P
C
Gupta
Healis
Sekhsaria
Ins]tute
for
Public
Health
India
9. CAUSES
OF
LUNG
CANCER:
SMOKING
Korea
has
one
of
the
highest
proporYons
of
male
smokers,
despite
the
country’s
relaYvely
small
populaYon
OECD
S.
Korea
17
percent
of
teenage
males
is
ligh]ng
up
a_er
their
daily
classes
Source: OECD (2013), Photo Credit: iPark3 – Smoking talks eden strategy institute | 9
Male
Smoking
ProporYon
10. CAUSES
OF
LUNG
CANCER:
NON-‐SMOKING
Apart
from
smoking,
non-‐smokers
in
Asia
are
also
contracYng
adenocarcinoma
lung
cancer
due
oncogenic
mutaYon
Source: Eden hospital interviews & analysis, Photo Credit: Ed Uthman – Adenocarcinoma of lung, FNA eden strategy institute | 10
“Adenocarcinoma
cancer
mainly
affects
the
terGary
bronchus
and
bronchioles,
areas
which
are
harder
to
diagnose
with
tradiGonal
methods”
Respiratory
Specialist
Taiwan
11. CAUSES
OF
LUNG
CANCER:
NON-‐SMOKING
This
is
compounded
with
the
effects
of
air
polluYon
from
the
different
sources
within
Asia
Second-‐Hand
Smoke
Forest
Fire
Asbestos
&
Radon
gas
from
building
materials
Industrial
PolluYon
Cooking
Oil
ParYcles
Indonesia
has
over
3,000
fire
alerts
in
from
20th
February
to
11th
March
in
2014
Source: World Resources Institute (2014), The World’s Worst Pollution Problems (2012), World Health Organization’s Tobacco-Free Initiative (2010) eden strategy institute | 11
Despite
the
toxicity
of
white
asbestos,
China
and
India
are
sYll
heavily
using
it
for
building
materials
India,
for
example,
has
produced
over
60,000
tons
of
industrial
waste
over
the
last
decade
Chinese-‐style
cooking
contributed
~30%
to
indoor
concentraYon
of
parYcles
from
0.5
to
5μm
Asia
has
one
of
the
highest
number
of
people
exposed
to
secondhand
smoke
12. CAUSES
OF
LUNG
CANCER:
NON-‐SMOKING
China,
for
instance,
has
witnessed
a
rise
in
non-‐smoking
lung
cancer
cases
due
to
severe
air
polluYon
in
the
past
few
years
eden strategy institute | 12
“Lung
cancer
caused
by
exposure
to
air
polluGon
is
increasing”
Wang
Ning
Deputy
Director
of
Cancer
Center
China
13. CAUSES
OF
LUNG
CANCER:
NON-‐SMOKING
Taiwan,
which
has
a
generally
low
smoking
rate,
is
also
seeing
high
incidences
of
non-‐smoking
lung
cancer
due
to
second-‐hand
smoke
“
96%
of
women
do
not
smoke,
but
are
inhaling
4
to
5
4mes
a
week
more
second-‐hand
smoke
at
home
than
in
the
work
place”
2010
Adult
Smoking
Behavior
Survey
Bureau
of
Health
Promo]on
Taiwan
60%
80%
40%
20%
0
1000
2000
3000
4000
5000
6000
7000
Male
Female
Non-‐Smoking
Lung
Cancer
Smoking
related
Lung
Cancer
New
Lung
Cancer
Incidence
by
gender
and
type
of
cancer
in
Taiwan
(2010)
Source: Eden hospital interviews & analysis eden strategy institute | 13
14. LUNG
CANCER
DEATHS
IntervenYons
for
lung
cancer
are
especially
criYcal
due
to
the
high
lung
cancer
death
rates
Source: Cancer Research UK 2014 eden strategy institute | 14
Lung
13%
Breast
12%
Bowel
10%
Prostate
8%
Others
57%
Most
Common
Cancers
Worldwide
14.1
million
new
cancer
cases
Most
Common
Cancers
Deaths
Worldwide
8.2
million
cancer
deaths
Lung
19%
Liver
9%
Stomach
9%
Prostate
8%
Others
55%
1.8
m
New
Lung
Cancer
Cases
Worldwide
(2012)
1.6
m
Lung
Cancer
Deaths
Worldwide
(2012)
15. LUNG
CANCER
PATIENT
PATHWAY
In
analyzing
the
drivers
of
lung
cancer
deaths,
we
found
that
most
countries
in
Asia
already
have
clear
paYent
pathways
Source: Eden hospital interviews & analysis eden strategy institute | 15
1.
IniYal
Screening
v
v
v
Radiologists
• Chest
X-‐Ray
• Chest
CT
ExaminaGon
• MRI
Check
• Bone
Scan
Treatment
with
surgery
Central:
Pulmonologist
• Brush
&
Forceps
Bronchoscopy
• X-‐ray
bronchoscopy
(C-‐arm)
• EBUS
–
TBNA
• EBUS-‐Radial
Peripheral:
Interven]onal
Radiologist
• CT-‐guided
TTNA
Hard-‐to-‐reach
areas:
Thoracic
Surgeons
• VATs
• Thoracoscopy
• MediasGnoscopy
• Wedge
ResecGon
• PET-‐CT:
Radiologists
• EBUS
TBNA:
Pulmonologists
2.
Medical
Imaging
3.
Biopsy
4.
Staging
(If
unsure
whether
tumor
has
spread)
Suspected
cases
Watchful
waiYng
• 3-‐
6
months
of
watchful
wai]ng
Regular
follow-‐ups
PosiYve
Diagnosis
Non-‐PosiYve
&
Inconclusive
Diagnosis
Non-‐cancer
False
negaGve
Misdiagnosis
5.
Decision
to
Operate
Stage
1
&
2
Operable
Stage
3
&
4
Inoperable
Chemotherapy
treatment
Tumor
Size
>2cm
• No
problem
in
locaGng
tumor
• PaGents
may
sGll
opt
for
surgery
• Watchful
waiGng
<1cm
3.
Lab
test
• Pathology
• Histology
• Difficult
to
diagnose
using
non-‐
surgical
methods
1-‐2
cm
Exhibit:
Gold
Standard
PaYent
Pathway
for
Lung
Cancer
Diagnosis
16. CHALLENGES
IDENTIFIED
However,
high
death
rates
remain
due
to
lack
of
screening,
inconsistent
skill
levels
among
doctors,
and
limitaYons
of
exisYng
tools
Source: Eden hospital interviews & analysis eden strategy institute | 16
1.
IniYal
Screening
v
v
v
Radiologists
• Chest
X-‐Ray
• Chest
CT
ExaminaGon
• MRI
Check
• Bone
Scan
Treatment
with
surgery
Central:
Pulmonologist
• Brush
&
Forceps
Bronchoscopy
• X-‐ray
bronchoscopy
(C-‐arm)
• EBUS
–
TBNA
• EBUS-‐Radial
Peripheral:
Interven]onal
Radiologist
• CT-‐guided
TTNA
Hard-‐to-‐reach
areas:
Thoracic
Surgeons
• VATs
• Thoracoscopy
• MediasGnoscopy
• Wedge
ResecGon
• PET-‐CT:
Radiologists
• EBUS
TBNA:
Pulmonologists
2.
Medical
Imaging
3.
Biopsy
4.
Staging
(If
unsure
whether
tumor
has
spread)
Suspected
cases
Watchful
waiYng
• 3-‐
6
months
of
watchful
wai]ng
Regular
follow-‐ups
PosiYve
Diagnosis
Non-‐PosiYve
&
Inconclusive
Diagnosis
Non-‐cancer
False
negaGve
Misdiagnosis
5.
Decision
to
Operate
Stage
1
&
2
Operable
Stage
3
&
4
Inoperable
Chemotherapy
treatment
Tumor
Size
>2cm
• No
problem
in
locaGng
tumor
• PaGents
may
sGll
opt
for
surgery
• Watchful
waiGng
<1cm
3.
Lab
test
• Pathology
• Histology
• Difficult
to
diagnose
using
non-‐
surgical
methods
1-‐2
cm
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
Lack
of
awareness
and
early
screening
leading
Exhibit:
Gold
Standard
PaYent
Pathway
for
Lung
Cancer
Diagnosis
17. Due
to
the
lack
of
noYceable
symptoms,
many
paYents
usually
get
diagnosed
and
treated
at
a
late
stage
of
lung
cancer
Source: Eden hospital interviews & analysis eden strategy institute | 17
Lack
of
awareness
and
early
screening
leading
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
Country
%
of
Late
Stage
Cancer
Average
77.8
China
80.0
Taiwan
80.0
India
85.0
Korea
66.0
CHALLENGES
IDENTIFIED
18. Free
screening
for
lung
cancer
remains
unavailable
in
Asia
for
the
public,
unlike
screening
for
breast
and
cervical
cancer
Source: Eden hospital interviews & analysis eden strategy institute | 18
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
CHINA
TAIWAN
INDIA
S.
KOREA
Free
Lung
Cancer
Health
Screening
No
No
No
No
Free
Breast
Cancer
Screening
Yes
Yes
Yes
Yes
Free
Cervical
Cancer
Screening
Yes
Yes
Yes
Yes
Countries
Studied
Lack
of
awareness
and
early
screening
leading
CHALLENGES
IDENTIFIED
19. In
addiYon,
the
level
of
skills
among
doctors
appears
to
be
inconsistent
across
countries,
and
even
within
the
same
country
Source: Eden hospital interviews & analysis eden strategy institute | 19
Lack
of
awareness
and
early
screening
leading
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
“There
is
a
limitaGon
to
how
far
we
can
go
in
to
the
lung
using
CT-‐guided
TTNA.
It’s
usually
only
5cm
from
chest
wall”
Respiratory
Specialist
Taiwan
“If
the
radiologist
is
experienced
enough,
then
every
posiGon
is
possible.
ComplicaGon
would
not
be
serious”
Respiratory
Specialist
Taiwan
Different
level
of
skills
with
CT-‐guided
TTNA
Different
amount
of
Yme
required
to
conduct
biopsy
“Doctor
can
find
the
tumor
using
EBUS
usually
within
ten
seconds.
The
enGre
procedure
will
be
completed
within
ten
minutes”
Pulmonologist
Taiwan
“We
take
around
30
to
40
minutes
per
EBUS-‐
TBNA
test”
Pulmonologist
Korea
CHALLENGES
IDENTIFIED
20. In
developing
markets
like
India,
lung
cancer
is
commonly
misdiagnosed
as
tuberculosis,
leading
to
late
treatment
Source: Eden hospital interviews & analysis eden strategy institute | 20
Lack
of
awareness
and
early
screening
leading
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
Symptoms
of
Pulmonary
Tuberculosis
• Persistent
cough
that
brings
up
phlegm,
which
may
be
bloody
• Mild
to
significant
breathlessnessXD
• Lack
of
appe]te
and
weight
loss
• High
temperature
of
38ºC
(100.4ºF)
or
above
• Night
Sweat
• Extreme
]redness
or
fa]gue,
accompanied
with
pain
*Symptoms
in
common
with
lung
cancer
Misdiagnosis
of
Lung
Cancer
as
Tuberculosis
“66%
of
the
lung
cancer
paGents
get
treated
for
TB”
Pulmonologis
India
–
Delhi
“Most
paGents
are
diagnosed
with
TB
and
come
to
the
pulmonologists
at
a
later
stage,
by
when
their
condiGon
has
already
worsened”
Pulmonologist,
India
-‐
Mumbai
CHALLENGES
IDENTIFIED
21. ExisYng
medical
imaging
tools
are
limited
in
their
ability
to
detect
early
stage
lung
cancer
Source: Eden hospital interviews & analysis eden strategy institute | 21
Lack
of
awareness
and
early
screening
leading
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
Chest
CT
Scan
PET
CT
Scan
Chest
X-‐Ray
MRI
Scan
Bone
Scan
CHALLENGES
IDENTIFIED
Method
Uses
electromagne]c
radia]on
to
generate
images
of
]ssues
and
structures
inside
the
body
Creates
3D
picture
of
the
inside
of
the
body
with
mul]ple
x-‐ray
Uses
magne]c
fields
to
produce
detailed
images
of
the
body
Radioac]ve
glucose
injected
into
body
to
find
tumors
Uses
a
radioac]ve
tracer
to
look
at
the
inside
of
the
bone
Func]on
Ini]al
test
to
detect
abnormal
shadowing
within
lungs
To
provide
precise
informa]on
about
size,
shape
and
posi]on
of
any
lung
tumors/
enlarged
lymph
nodes
Metastasis
detec]on
for
brain
Typically
used
for
staging.
Full
body
tes]ng
for
cancer
Metastasis
detec]on
for
bones
Strengths
Quick,
simple
&
cheap
Ability
to
spot
very
small
lung
tumors,
and
help
determine
exact
loca]on
and
extent
of
tumors
Ability
to
see
size
and
loca]on
of
lung
cancer
metastases
Ability
to
test
for
metastasis
Ability
to
test
for
metatasis
Limita]ons
Unable
to
detect
small
lung
tumors
Insufficient
to
confirm
cancer
Rarely
used
for
lungs
as
lung
is
always
moving
Costly.
High
false
posi]ve
for
tuberculosis
pa]ents
Replaced
by
PET
CT
scan
to
find
lung
cancer
that
has
spread
to
the
bones
22. TradiYonal
biopsy
tools
are
olen
only
able
to
reach
up
to
terYary
bronchi,
with
problems
accessing
parts
near
the
nerves
and
heart
Source: Eden hospital interviews & analysis eden strategy institute | 22
Lack
of
awareness
and
early
screening
leading
Inconsistent
skill
levels
and
misdiagnosis
Limita]ons
of
exis]ng
methods
&
equipment
Primary
&
Secondary
Bronchus
can
be
reached
with
tradiYonal
biopsy
tools
Lung
regions
that
are
difficult
to
access
TerYary
Bronchus,
that
can
be
reached
with
bronchoscopes
&
EBUS
RP
TradiYonal
Bronchoscopy
EBUS
radial
probe
(RP)
EBUS
radial
probe
(RP):
Blind
CHALLENGES
IDENTIFIED
23. Source: Eden hospital interviews & analysis eden strategy institute | 23
SOLUTION
SPACE
Successfully
tackling
lung
cancer
requires
close
collaboraYon
among
governments,
hospitals,
and
various
stakeholders
for
shared
benefits
Government
Hospitals
Doctors
Medical
Device
Companies
NGOs
Insurance
Companies
COUNTRY
LUNG
CANCER
STRATEGY
• Raising
awareness
of
lung
cancer
and
its
links
with
smoking
• Advoca]ng
/
subsidizing
free
screening
for
high
risk
individuals
• Raising
awareness
on
risk
of
smoking
and
benefits
of
early
screening
• Assessing
healthcare
economics
of
subsidizing
lung
cancer
diagnosis
and
treatment
• Capacity
building
to
ensure
consistency
of
skills
and
reduce
cases
of
misdiagnosis
• Conference
s
to
share
best
prac]ce
cases
• Working
with
hospitals
and
government
to
provide
comprehensive
coverage
for
lung
cancer
screening
• Sharing
of
knowledge
and
training
• Con]nual
learning
and
upgrading
of
skills
• R&D
on
improving
lung
cancer
biopsy
and
treatment
Medical
Schools
• Collabora]ng
with
medical
device
companies
to
conduct
research
• Consistent
method
of
providing
training
to
doctors
24. Source: Want China Times (2012) Taipei Times (2012), Ministry of Health and Welfare (2014) Photo Credit: Taiwan Health Promotion Administration (2012) eden strategy institute | 24
The
government
in
Taiwan,
for
instance,
has
worked
together
with
hospitals
and
clinics
in
local
communiYes
on
a
series
of
smoking
cessaYon
campaigns
through
educaYon
and
support
“Thanks
to
the
program,
an
es4mated
NT
$900
million
(US$30.1million)
in
medical
expenditure
will
be
save
in
the
short
term
and
a
much
greater
amount
in
the
long
term”
Taiwan
Former
Premier
Jiang
Yi-‐Huah
SOLUTION
SPACE
EducaYon
Regulatory
Changes
Support
&
Counseling
Financial
IncenYve
• First
smoke-‐free
hospital
network
in
the
Asia-‐Pacific
region
in
2010,
with
113
ins]tu]ons
joining
• 2,151
hospitals
providing
new
Quit
Smoking
Services
Impact
(Since
2012)
• Served
630,000
people
• Helped
more
than
160,000
people
to
quit
• “Quit
Smoking,
Smoke-‐free
Taipei
Program”
provides
4
weeks
of
free
medica]on
and
medical
advise
• Program
funding
by
Na]onal
Health
Insurance
scheme
• Extended
smoke-‐free
areas
to
include
most
enclosed
work-‐places
and
public
places
• Adding
graphic
health
warnings
to
cigarese
packages
and
banning
of
tobacco
adver]sements
• Media
campaigns
on
public
awareness
and
secondhand
smoke
exposure
25. Source and Photo Credit: Norwalk Hospital (2014) eden strategy institute | 25
Norwalk
hospital,
in
the
US,
also
offers
free
low-‐dose
lung
CT
screening
for
high
risk
paYents
to
encourage
early
diagnosis
Qualifying
criteria
• Aged
between
55
and
80
• Have
smoked
within
the
last
15
years
• Have
a
30+
pack
year
smoking
history
“Researchers
found
that
screening
with
low-‐dose
lung
CT
screening
significantly
reduced
the
mortality
rate
from
lung
cancer
by
20
percent”
Norwalk
Hospital
(2014)
Free
Lung
Cancer
Screening
Program
Includes:
• Low-‐dose
lung
CT
screening
• Scan
of
the
coronary
arteries
• Three
personalized
smoking
cessa]on
classes
for
current
smokers
who
wish
to
quit
SOLUTION
SPACE
26. Source: Eden medical device company and hospital interviews & analysis eden strategy institute | 26
Breakthroughs
in
lung
cancer
biopsy
technologies
can
also
address
the
limitaYon
of
exisYng
methods
Employing
EBUS
radial
probe
together
with
ENB
as
a
safer
and
more
comfortable
early
stage
peripheral
diagnosis
tools
Primary
&
Secondary
Bronchus
can
be
reached
with
tradiYonal
biopsy
tools
Lung
regions
that
are
difficult
to
access
TerYary
Bronchus,
which
can
be
reached
with
bronchoscopes
&
EBUS
RP
TradiYonal
Bronchoscopy
ENB
EBUS
radial
probe
(RP)
EBUS
radial
probe
(RP):
Blind
ENB
(Blind)
Bronchioles,
which
can
be
reached
with
EBUS
RP
and
ENB
Endobrochial
Ultrasound
Bronchoscopy
Radial
Probe
(EBUS
RP)
Electromagne]c
Naviga]on
Bronchoscopy
(ENB)
SOLUTION
SPACE
27. Source: NY Daily News (2014), Photo Credit: American Friends of Tel Aviv University eden strategy institute | 27
The
possibility
of
a
breathalyzer
for
lung
cancer
diagnosis
is
also
in
its
research
and
development
stage
SOLUTION
SPACE
28. Preventable
deaths
from
lung
cancer
can
be
reduced
with
widespread
awareness-‐building
smoking
and
early
screening,
subsidized
lung
cancer
screening
on
a
systemaYc
level,
adopYon
of
recent
technological
advancements,
and
capacity-‐building
among
medical
teams
eden strategy institute | 28
29. • Eden’s
Healthcare
PracYce.
Eden
Strategy
Ins]tute
approaches
the
global
issues
of
disease,
poverty,
illiteracy,
and
exploita]on
head-‐on,
by
formula]ng
strategies,
models,
processes,
products,
and
designs
that
help
our
clients
create,
realize,
and
sustain
quantum
profit
in
addressing
these
issues.
Our
experience
spans
the
en]re
healthcare
system,
from
R&D
at
medical
technology
firms,
pharmaceu]cal
companies,
and
biotechnology
ins]tu]ons,
to
commercializa]on,
manufacturing,
downstream
distribu]on,
hospital
installa]on
and
management.
We
have
an
extensive
network
of
contacts
with
the
en]re
healthcare
ecosystem
across
Asia-‐Pacific.
• Sustainability
in
healthcare.
Eden
brings
sustainability
to
the
Healthcare
sector
by
suppor]ng
governments
with
policy
and
infrastructure
development,
helping
research
ins]tu]ons
go-‐to-‐market
while
protec]ng
and
managing
their
innova]on
pipelines,
planning
the
market
entry
of
medtech
firms,
hospitals,
and
pharma
companies,
suppor]ng
healthcare
educa]on
to
raise
pa]ent
awareness,
facilita]ng
the
flow
of
medical
tourists,
assis]ng
in
API
manufacturing
and
vaccine
distribu]on,
assessing
treatment
efficacy,
and
working
with
health
insurers
and
reimbursement
systems
to
improve
treatment
quality
while
reducing
costs.
• Our
philosophy.
We
believe
in
the
power
of
ideas
to
posi]vely
shape
our
world,
one
client
at
a
]me.
Our
focus
is
unparalleled
in
bringing
to
bear
our
en]re
senior
management
team,
as
well
as
the
world’s
foremost
experts,
on
our
clients’
most
pressing
sustainability
issues.
In
turn,
we
elect
to
only
collaborate
with
clients
who
are
seriously
commised
to
crea]ng
value
together.
Asia’s
Leader
in
Social
InnovaYon
ConsulYng
eden strategy institute
30. eden strategy institute
Contacts:
Calvin
Chu
Yee
Ming,
Partner
Amanda
Tan,
Strategy
Analyst
Eden
Strategy
Ins]tute
T:
+65
9751
5817
E:
query@edenstrategyins]tute.com
www.edenstrategyins]tute.com
Thank
you